Predictive factors for prolonged response to olaparib as maintenance therapy in ovarian cancer patients with BRCA mutations.

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume 36, Issue 15_suppl, Pages 5558-5558

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2018-09-05

DOI

10.1200/jco.2018.36.15_suppl.5558

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started